+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Les Laboratoires Servier SAS - Strategic SWOT Analysis Review

Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

Les Laboratoires Servier SAS (Servier) researches, develops, manufactures, and markets drugs for treating various diseases. The company's portfolio of marketed products treats central nervous system (CNS) disorders, cardiovascular diseases, cancer, ENT disorders, respiratory diseases, hematological disorders, hormonal disorders, and others. The company also provides generic drugs and contract development and manufacturing services across its global network. The company also provides digital therapeutic solutions through its e-health division, WeHealth Digital Medicine. It sells products in Europe, America, Middle East, Africa, and Asia. Servier headquartered in Suresnes, Ile-de-France, France.

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with the detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • Les Laboratoires Servier SAS - Key Facts
  • Les Laboratoires Servier SAS - Key Employees
  • Les Laboratoires Servier SAS - Key Employee Biographies
  • Les Laboratoires Servier SAS - Major Products and Services
  • Les Laboratoires Servier SAS - History
  • Les Laboratoires Servier SAS - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Les Laboratoires Servier SAS - Business Description
  • Les Laboratoires Servier SAS - SWOT Analysis
  • SWOT Analysis - Overview
  • Les Laboratoires Servier SAS - Strengths
  • Les Laboratoires Servier SAS - Weaknesses
  • Les Laboratoires Servier SAS - Opportunities
  • Les Laboratoires Servier SAS - Threats
  • Les Laboratoires Servier SAS - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Les Laboratoires Servier SAS, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Apr 26, 2023: Changes to the Executive Committee of Servier Group
  • Apr 07, 2023: Mécénat Servier’s 2021/2022 Annual Report is now available!
  • Mar 31, 2023: Specifica announces antibody discovery platform transfer agreement with Servier and its subsidiary symphogen
  • Mar 15, 2023: Hypertension: OMRON Healthcare and Servier announce a long-term strategic partnership
  • Mar 10, 2023: Qiagen partners with Servier to develop new test for AML drug
  • Mar 10, 2023: For the first time, Servier is publishing an Integrated Annual Report
  • Feb 17, 2023: Paris-Saclay: our R&D Institute opens its doors!
  • Feb 15, 2023: Accelerating our commitment to pediatric cancers
  • Feb 02, 2023: Groupe Servier's results for the 2021/22 financial year confirm its transformation trajectory
  • Dec 15, 2022: OPM and Servier launch"FederAidd", an international virtual campus for open innovation to accelerate and make the drug discovery process more reliable thanks to Artificial Intelligence
Section 5 - Appendix
  • Methodology
  • About the Publisher
  • Contact Us
  • Disclaimer
List of Tables
  • Les Laboratoires Servier SAS, Key Facts
  • Les Laboratoires Servier SAS, Key Employees
  • Les Laboratoires Servier SAS, Key Employee Biographies
  • Les Laboratoires Servier SAS, Major Products and Services
  • Les Laboratoires Servier SAS, History
  • Les Laboratoires Servier SAS, Subsidiaries
  • Les Laboratoires Servier SAS, Key Competitors
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
  • Les Laboratoires Servier SAS, Recent Deals Summary
List of Figures
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
  • Les Laboratoires Servier SAS, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Inato
  • Sanofi
  • Ipsen SA
  • Laboratoires Thea SA
  • NicOx SA
  • Laboratoires Pierre Fabre SA
  • Pfizer Inc